Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > New hiring position

<< Previous

Bullboard Posts

Next >>

Comment by pelabooston Dec 16, 2023 11:29am

138 Views

Post# 35788222

RE:RE:New hiring position

@CMH. It was me that said we had a good writer; I was referring to the current CMO. It appears that the new writer will report to the CMO.

I would assume we are adding an employee, and presuming our current CMO will be attending to weightier matters than writing.

This all costs money; let us hope there is something in the Xmas stocking.

<< Previous

Bullboard Posts

Next >>

Two Canadian cannabis stocks just signed transformative agreements